VAL.L Gross Margin

The Gross Margin of ValiRx PLC (VAL.L) is -19.92%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

VAL.L Gross Margin - Historical Value

Date	Value
2024-12-31	-19.92%
2023-12-31	85.00%

VAL.L Gross Margin - Peers Comparison

Ticker	Name	Value
ALPAT.PA	Plant Advanced Technologies PAT SA	116.00%
EVG.L	Evgen Pharma PLC	-1151.58%
GV.PA	Genomic Vision SA	-165.01%
IMCR	Immunocore Holdings PLC	98.73%
MYOV	Myovant Sciences Ltd	77.68%
PROMO.ST	Promore Pharma AB	-124472.22%
ACTI.ST	Active Biotech AB publ	100.00%
ADAP	Adaptimmune Therapeutics PLC	99.96%
RDG.WA	Read Gene SA	93.56%
LIDDS.ST	Lidds AB	-1102.81%
XINT.ST	Xintela AB	100.00%
AEGIR.ST	Aegirbio AB	47.83%
CNTA	Centessa Pharmaceuticals PLC	7775.20%
OXB.L	Oxford Biomedica PLC	39.10%
TOL.ST	Toleranzia AB	1842.86%
GEN.WA	Genomed SA	66.36%
GUARD.ST	Guard Therapeutics International AB (publ)	100.00%
IDOGEN.ST	Idogen AB	7775.20%
IKM.MC	1nkemia IUCT Group SA	227.85%
ISR.ST	ISR Immune System Regulation Holding AB (publ)	-45046.17%
SENZA.ST	SenzaGen AB	64.80%
ALZ.ST	Alzinova AB	-32946.67%
CMPS	Compass Pathways PLC	7775.20%
COMBI.ST	Combigene AB	-14.34%
SCS.WA	Stem Cells Spin SA	92.62%
ABC.L	Abcam PLC	71.12%
ABNX.PA	Abionyx Pharma SA	13.14%
IMMU.ST	Mendus AB (publ)	7775.20%
MTPH.L	Midatech Pharma PLC	94.91%
ALLR.ST	Allarity Therapeutics A/S	-175.91%
GNS.L	Genus PLC	32.36%
SLN.L	Silence Therapeutics PLC	3133.78%
SPRINT.ST	Sprint Bioscience AB	92.18%
ALNEV.PA	Neovacs SA	-61.86%
BCYC	Bicycle Therapeutics PLC	7775.20%
ALPRE.PA	Predilife SA	97.20%